Delivery Order SPE2DB22D3501-SPE2DB25FWR05
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,177.63 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhaler 8.5 gm, with an ultimate completion date of September 11, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader supply relationship with the federal government for...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,445.76 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,588.48 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM, a commonly prescribed bronchodilator medication used in respiratory treatment. The award, issued on September 15, 2025, with completion targeted for September 16, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.06 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,001.00 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams). The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,339.76 for Albuterol HFA 90 mcg inhalers (8.5 gm) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,773.92 to AmerisourceBergen Drug Corp for Albuterol HFA 90 micrograms inhalers (8.5 grams) on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWR05Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,863.66 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of July 31, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical supply chain, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency requirements and other federal healthcare customers. This specific delivery order for respiratory medication aligns with AmerisourceBergen's established portfolio of federal medical product deliveries across multiple therapeutic domains and demonstrates the company's capability to fulfill specialized pharmaceutical needs through the DLA's global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/30/25 |